"Hydroxychloroquine is FDA approved and has been used for years by patients with Lupus, rheumatoid arthritis and other autoimmune disorders", Barai, an oncologist affiliated with the Community Hospital in Munster, Indiana, said.
In the very early stages of the viral outbreak, doctors in China experimented with a number of different pre-existing drugs in the hopes that something could be repurposed to prevent infection, or at least improve patient outcomes. But that hasn't stopped Trump from repeatedly touting the unproven treatment as a "game-changer" in the fight against covid-19.
For the findings, they evaluated data of more than 96,000 COVID-19 patients in 671 hospitals, taking one of the drugs, with or without an antibiotic such as azithromycin, between 20 December and 14 April.
On the other hand, the risk of death was found to be higher in those treated with HCQ than those treated otherwise.
The study is of course not the final word on hydroxychloroquine for treating COVID-19.
Amidst the debate about the safety of hydroxychloroquine, the Indian Council of Medical Research (ICMR) has expanded the use of this drug as a preventive treatment against COVID-19.
China reports three new coronavirus cases after first day with none
Sunday marks the 61st straight day of ongoing lockdown across the country to contain the spread of the pandemic. As many as 58 people have recovered from the infection while four people have succumbed to the infection.
Chloroquine has not yet been shown to be safe and effective in the prevention or treatment of coronavirus and the World Health Organization has warned that individuals who self-medicate risk causing themselves serious harm.
Al Mason added that Trump's critics and his political opponents opposed him for using Hydroxychloroquine and "tried to sabotage the drug's clinical trial".
"A lot of good things have come out about the hydroxy". He points out, no definitive answer will be clear until larger clinical trials deliver results.
The WHO emphasized that the other arms of the solidarity trial will proceed.
Another drug that is being considered as a potential cure for the fatal respiratory pandemic is the broad-spectrum antiviral favipiravir, for which various trials are underway.
World Health Organization chief Tedros Adhanom Ghebreyesus told reporters that the clinical trials involving the drug had been "suspended while the safety is reviewed". There's no signals from the Solidarity trials that indicate any problem and the decision was made out of an "abundance of caution", Ryan said.
A "temporary pause" of the WHO's hydroxychloroquine trial was instituted while "safety data is reviewed", said WHO Director General Tedros Adhanom Ghebreyesus.